JP2005513006A5 - - Google Patents

Download PDF

Info

Publication number
JP2005513006A5
JP2005513006A5 JP2003543529A JP2003543529A JP2005513006A5 JP 2005513006 A5 JP2005513006 A5 JP 2005513006A5 JP 2003543529 A JP2003543529 A JP 2003543529A JP 2003543529 A JP2003543529 A JP 2003543529A JP 2005513006 A5 JP2005513006 A5 JP 2005513006A5
Authority
JP
Japan
Prior art keywords
compound according
biologically active
residues
residue
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003543529A
Other languages
English (en)
Japanese (ja)
Other versions
JP4663233B2 (ja
JP2005513006A6 (ja
JP2005513006A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/035871 external-priority patent/WO2003041642A2/en
Publication of JP2005513006A publication Critical patent/JP2005513006A/ja
Publication of JP2005513006A6 publication Critical patent/JP2005513006A6/ja
Publication of JP2005513006A5 publication Critical patent/JP2005513006A5/ja
Application granted granted Critical
Publication of JP4663233B2 publication Critical patent/JP4663233B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2003543529A 2001-11-09 2002-11-08 ベンジル脱離系を利用する高分子チオール結合プロドラッグ Expired - Fee Related JP4663233B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US34491201P 2001-11-09 2001-11-09
US60/344,912 2001-11-09
US36732002P 2002-03-25 2002-03-25
US60/367,320 2002-03-25
PCT/US2002/035871 WO2003041642A2 (en) 2001-11-09 2002-11-08 Polymeric thiol-linked prodrugs employing benzyl elimination systems

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010093856A Division JP2010195810A (ja) 2001-11-09 2010-04-15 ベンジル脱離系を利用する高分子チオール結合プロドラッグ

Publications (4)

Publication Number Publication Date
JP2005513006A JP2005513006A (ja) 2005-05-12
JP2005513006A6 JP2005513006A6 (ja) 2005-08-04
JP2005513006A5 true JP2005513006A5 (https=) 2006-01-05
JP4663233B2 JP4663233B2 (ja) 2011-04-06

Family

ID=26994160

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2003543529A Expired - Fee Related JP4663233B2 (ja) 2001-11-09 2002-11-08 ベンジル脱離系を利用する高分子チオール結合プロドラッグ
JP2010093856A Pending JP2010195810A (ja) 2001-11-09 2010-04-15 ベンジル脱離系を利用する高分子チオール結合プロドラッグ

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010093856A Pending JP2010195810A (ja) 2001-11-09 2010-04-15 ベンジル脱離系を利用する高分子チオール結合プロドラッグ

Country Status (6)

Country Link
US (1) US7262164B2 (https=)
EP (1) EP1450844A4 (https=)
JP (2) JP4663233B2 (https=)
AU (1) AU2002359364A1 (https=)
CA (1) CA2465090C (https=)
WO (1) WO2003041642A2 (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60234858D1 (de) * 2001-11-09 2010-02-04 Enzon Inc Polyalkylenoxid-Konjugate von thiolhaltigen Arzneistoffen
WO2005070921A1 (en) * 2004-01-23 2005-08-04 Elan Pharmaceuticals, Inc. Polyethylene glycol conjugates of heterocycloalkyl carboxamido propanoic acids
WO2006015318A2 (en) * 2004-07-30 2006-02-09 Biogen Idec Inc. Antibody conjugated to a drug moiety via a poptidic linker
ATE465205T1 (de) * 2005-12-05 2010-05-15 Nitto Denko Corp Polyglutamat-aminosäure-konjugate und verfahren
PT2155255E (pt) 2007-05-09 2013-10-15 Nitto Denko Corp Composições que incluem um composto hidrofóbico e um conjugado de poliaminoácido
US20090092664A1 (en) * 2007-10-08 2009-04-09 University Of Kentucky Research Foundation Polymer-metal chelator conjugates and uses thereof
CN104945420A (zh) 2009-06-29 2015-09-30 因塞特公司 作为pi3k抑制剂的嘧啶酮类
US8680108B2 (en) * 2009-12-18 2014-03-25 Incyte Corporation Substituted fused aryl and heteroaryl derivatives as PI3K inhibitors
WO2011075643A1 (en) 2009-12-18 2011-06-23 Incyte Corporation Substituted heteroaryl fused derivatives as pi3k inhibitors
AR081823A1 (es) 2010-04-14 2012-10-24 Incyte Corp DERIVADOS FUSIONADOS COMO INHIBIDORES DE PI3Kd
US9062055B2 (en) 2010-06-21 2015-06-23 Incyte Corporation Fused pyrrole derivatives as PI3K inhibitors
EP2655374B1 (en) 2010-12-20 2019-10-23 Incyte Holdings Corporation N-(1-(substituted-phenyl)ethyl)-9h-purin-6-amines as pi3k inhibitors
US9108984B2 (en) 2011-03-14 2015-08-18 Incyte Corporation Substituted diamino-pyrimidine and diamino-pyridine derivatives as PI3K inhibitors
WO2012135009A1 (en) 2011-03-25 2012-10-04 Incyte Corporation Pyrimidine-4,6-diamine derivatives as pi3k inhibitors
KR102507287B1 (ko) 2011-09-02 2023-03-07 인사이트 홀딩스 코포레이션 Ｐｉ３ｋ 억제제로서 헤테로시클릴아민
AR090548A1 (es) 2012-04-02 2014-11-19 Incyte Corp Azaheterociclobencilaminas biciclicas como inhibidores de pi3k
TWI636046B (zh) 2013-05-17 2018-09-21 美國禮來大藥廠 苯氧基乙基二氫－１ｈ－異喹啉化合物
WO2015191677A1 (en) 2014-06-11 2015-12-17 Incyte Corporation Bicyclic heteroarylaminoalkyl phenyl derivatives as pi3k inhibitors
SI3831833T1 (sl) 2015-02-27 2023-03-31 Incyte Holdings Corporation Postopki za pripravo inhibitorja PI3K
US9732097B2 (en) 2015-05-11 2017-08-15 Incyte Corporation Process for the synthesis of a phosphoinositide 3-kinase inhibitor
US9988401B2 (en) 2015-05-11 2018-06-05 Incyte Corporation Crystalline forms of a PI3K inhibitor
WO2019010231A1 (en) * 2017-07-05 2019-01-10 Duke University APPARATUS AS TARGETED PRODRUGS FOR PROSTATE CANCER AND METHODS OF MAKING AND USING THE SAME
CA3101323A1 (en) 2018-06-01 2019-12-05 Incyte Corporation Dosing regimen for the treatment of pi3k related disorders

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2944902A (en) * 1956-07-30 1960-07-12 Eastman Kodak Co Sensitization of photographic emulsions with ionic polyalkylene oxide salts
DE2343147C2 (de) * 1973-08-27 1982-06-09 Henkel KGaA, 4000 Düsseldorf Pyrrolidon-5,5-diphosphonsäuren, deren wasserlösliche Salze, und Verfahren zu ihrer Herstellung
US4479002A (en) * 1975-12-01 1984-10-23 Union Carbide Corporation Carbamate-carbamoyl fluoride compounds
US4623715A (en) * 1984-10-22 1986-11-18 Hoechst Aktiengeselleschaft Novel peptides which are active on the central nervous system and have an action on the cholinergic system
US4772586A (en) * 1985-01-23 1988-09-20 Medical College Of Ohio Novel derivatives of arginine vasopressin antagonists
US5112739A (en) 1988-08-02 1992-05-12 Polaroid Corporation Enzyme controlled release system
JPH05132431A (ja) * 1990-03-28 1993-05-28 Nippon Oil & Fats Co Ltd 高分子化薬剤およびその製造法
US5130126A (en) * 1990-07-09 1992-07-14 Nippon Oil & Fats Co., Ltd. Polymer-drug conjugate and a method of producing it
US5245032A (en) * 1990-09-20 1993-09-14 Union Carbide Chemicals & Plastics Technology Corporation Catalytic processes for the preparation of n,n,n-trisubstituted nitrogen-containing compounds
US5681811A (en) * 1993-05-10 1997-10-28 Protein Delivery, Inc. Conjugation-stabilized therapeutic agent compositions, delivery and diagnostic formulations comprising same, and method of making and using the same
AU7932494A (en) * 1993-10-13 1995-05-04 Valence Technology, Inc. Solid electrolytes containing oxyalkylene solvents and/or oxyalkylene polymers and electrolytic cells produced therefrom
US5880131A (en) * 1993-10-20 1999-03-09 Enzon, Inc. High molecular weight polymer-based prodrugs
US5932462A (en) * 1995-01-10 1999-08-03 Shearwater Polymers, Inc. Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
US6255361B1 (en) * 1995-11-21 2001-07-03 Acushnet Company Golf ball compositions and method of making same
CA2245922A1 (en) * 1996-12-13 1998-06-18 Shun-Ichi Ikeda Dc 107 derivatives (2)
WO1999030727A1 (en) * 1997-12-17 1999-06-24 Enzon, Inc. Polymeric prodrugs of amino- and hydroxyl-containing bioactive agents
US6765019B1 (en) 1999-05-06 2004-07-20 University Of Kentucky Research Foundation Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids
DE60234858D1 (de) * 2001-11-09 2010-02-04 Enzon Inc Polyalkylenoxid-Konjugate von thiolhaltigen Arzneistoffen

Similar Documents

Publication Publication Date Title
JP2005513006A5 (https=)
NO2025027I1 (no) Pharmaceutical mixture or association that includes as active ingredients: (1) ceftazidime or a salt thereof, and (2) avibactam or a pharmaceutically acceptable salt thereof - forlenget.
JP2004529078A5 (https=)
JP2004532810A5 (https=)
PL375357A1 (pl) Ulepszona ekstrakcja składników farmaceutycznie aktywnych z materiałów roślinnych
GEP20063890B (en) Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
RU2325389C2 (ru) Композиция и производные замещенного азаиндолоксоацетапиперазина, обладающие противовирусной активностью
IL164699A (en) Derivatives of diketohydrazine compounds and pharmaceutical compositions and medicaments containing the compounds as the active ingredient
JP2003503454A5 (https=)
JP2004515500A5 (https=)
IL163130A (en) Tripeptides having a hydroxyproline thereof a substituted quinoline, pharmaceutical compositions comprising them and their use in the manufacture of medicaments for the inhibition of ns3 (hepatitis c)
WO2006044362A3 (en) N-sulfonylpiperidine cannabinoid receptor 1 antagonists
NO20043367L (no) Oralt farmasoytisk preparat
EA200400664A1 (ru) Фармацевтические композиции, включающие метформин и глибенкламид, применяемые для лечения сахарного диабета типа ii
HUP0203176A2 (hu) Szimetikont tartalmazó orális, szilárd adagolási forma
WO2004030611A3 (en) Non-nucleoside reverse transcriptase inhibitors
SE0102036D0 (sv) Pharmaceutical formulation for the efficient administration of apomorphine, 6aR- (-) -N- Propyl- norapomorphine and their derivatives and pro-drugs thereof
NO20040881L (no) Orale antidiabetes midler.
SE0302116D0 (sv) Novel compounds
ATE386725T1 (de) Heterocyclylverbindungen
JP2007520565A5 (https=)
ATE454385T1 (de) Hiv-integrase-hemmers, pharmazeutischen zusammensetzung und ihre anwendung
WO2003066597A3 (en) Guanidino compounds
MA28862B1 (fr) Composition pharmaceutique sous forme de comprime a residence gastrique contenant un principe actif
ATE521349T1 (de) Antimykotische medizinische zusammensetzungen